Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Phosphorylation-dependent ubiquitination combined with proteasomal degradation of transcriptional regulators is a recently appreciated mechanism for control of a number of inflammatory genes. Far less is known about the counterregulatory mechanisms that repress transcriptional activity in these pathways during resolution. Here, we investigated the transient nature of hypoxia-induced tumor necrosis factor (TNF)α in T84 cells, a process we have previously shown to involve phosphorylation-dependent degradation of the cAMP-response element-binding protein (CREB). Initial studies indicate hypoxia-induced TNFα to be a transient event, the resolution of which is associated with the appearance of a higher molecular weight modified form of CREB. Gene array analysis of mRNA derived from hypoxic cells identified a time-dependent induction of small ubiquitin-related modifier (SUMO)-1 mRNA. In prolonged hypoxia, CREB is posttranslationally modified by SUMO-1. Furthermore, SUMO-1 overexpression stabilizes CREB in hypoxia and enhances CREB-dependent reporter gene activity. Site-directed mutagenesis of lysine residues K285 and K304 identifies them as SUMO acceptors in vivo and in vitro . Mutation of K304 also results in loss of CREB nuclear localization, implying a role for SUMO-1 modification at this site in the subcellular localization of CREB. Thus, in prolonged hypoxia, CREB is modified by association with SUMO-1. Furthermore, we hypothesize that such an event stabilizes and promotes nuclear localization of CREB and thus complements an endogenous resolution phase for hypoxia-induced inflammatory processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intriguingly, SUMO1 is itself hypoxia inducible, suggesting that sumoylation of HIFα, and other targets, modifies the response to hypoxia (Comerford et al., 2003; Lee et al., 2007).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Comerford et al., 2003
Citations
Cites
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Expression monitoring by hybridization to high-density oligonucleotide arrays
Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Norton, H., et al. (1996) · Nature Biotechnology · doi:10.1038/nbt1296-1675 · Cited by 2,840
Transcriptional regulation by the phosphorylation-dependent factor CREB
Mayr, B., & Montminy, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085068 · Cited by 2,587
RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO
Hoege, C., Pfander, B., Moldovan, G.-L., Pyrowolakis, G., & Jentsch, S. (2002) · Nature · doi:10.1038/nature00991 · Cited by 2,198
Mahajan, R., Delphin, C., Guan, T., Gerace, L., & Melchior, F. (1997) · Cell · doi:10.1016/s0092-8674(00)81862-0 · Cited by 1,256
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. O. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,172
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity
Pichler, A., Gast, A., Seeler, J. S., Dejean, A., & Melchior, F. (2002) · Cell · doi:10.1016/s0092-8674(01)00633-x · Cited by 816
Melchior, F. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.591 · Cited by 774
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting
Rodriguez, M. S., Dargemont, C., & Hay, R. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009476200 · Cited by 744
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
SUMO-1 modification activates the transcriptional response of p53
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
Disruption of Signaling by Yersinia Effector YopJ, a Ubiquitin-Like Protein Protease
Orth, K., Xu, Z., Mudgett, M. B., Bao, Z. Q., Palmer, L. E., Bliska, J. B., Mangel, W. F., Staskawicz, B., & Dixon, J. E. (2000) · Science · doi:10.1126/science.290.5496.1594 · Cited by 542
Sampson, D. A., Wang, M., & Matunis, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100006200 · Cited by 519
Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., Scheffner, M., & Del Sal, G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6462 · Cited by 513
Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honoré, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1361 · Cited by 488
Matunis, M. J., Wu, J., & Blobel, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.3.499 · Cited by 464
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
Poukka, H., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14145 · Cited by 457
Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity
Schmidt, D., & Müller, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052559499 · Cited by 448
c-Jun and p53 Activity Is Modulated by SUMO-1 Modification
Müller, S., Berger, M., Lehembre, F., Seeler, J.-S., Haupt, Y., & Dejean, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13321 · Cited by 400
Covalent Modification of p73α by SUMO-1
Minty, A., Dumont, X., Kaghad, M., & Caput, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004293200 · Cited by 388
TAT-Mediated Protein Transduction into Mammalian Cells
Becker-Hapak, M., McAllister, S. S., & Dowdy, S. F. (2001) · Methods · doi:10.1006/meth.2001.1186 · Cited by 384
Identification of the Enzyme Required for Activation of the Small Ubiquitin-like Protein SUMO-1
Desterro, J. M. P., Rodriguez, M. S., Kemp, G. D., & Hay, R. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10618 · Cited by 380
Ubch9 conjugates SUMO but not ubiquitin
Desterro, J. M. P., Thomson, J., & Hay, R. T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01305-7 · Cited by 365
Mahajan, R., Gerace, L., & Melchior, F. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.2.259 · Cited by 289
Regulation of Heat Shock Transcription Factor 1 by Stress-induced SUMO-1 Modification
Hong, Y., Rogers, R., Matunis, M. J., Mayhew, C. N., Goodson, M., Park-Sarge, O.-K., & Sarge, K. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104714200 · Cited by 266
Sternsdorf, T., Jensen, K., Reich, B., & Will, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12555 · Cited by 264
Aggarwal, B. B. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i6 · Cited by 235
In VitroSUMO-1 Modification Requires Two Enzymatic Steps, E1 and E2
Okuma, T., Honda, R., Ichikawa, G., Tsumagari, N., & Yasuda, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9995 · Cited by 233
Salnikow, K., Kluz, T., Costa, M., Piquemal, D., Demidenko, Z. N., Xie, K., & Blagosklonny, M. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1734-1741.2002 · Cited by 207
Taylor, C. T., Dzus, A. L., & Colgan, S. P. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70579-7 · Cited by 188
Self-citationBies, J., Markus, J., & Wolff, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110453200 · Cited by 182
Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor
TIAN, S., POUKKA, H., PALVIMO, J. J., & JÄNNE, O. A. (2002) · Biochemical Journal · doi:10.1042/bj20021085 · Cited by 182
Hofmann, H., Flöss, S., & Stamminger, T. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2510-2524.2000 · Cited by 164
Kim, Y. H., Choi, C. Y., & Kim, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12350 · Cited by 161
The HIV-1 Tat Nuclear Localization Sequence Confers Novel Nuclear Import Properties
Efthymiadis, A., Briggs, L. J., & Jans, D. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1623 · Cited by 160
Potentiation of glucocorticoid receptor transcriptional activity by sumoylation
Le Drean, Y., Mincheneau, N., Le Goff, P., & Michel, D. (2002) · Endocrinology · doi:10.1210/en.2002-220135 · Cited by 159
SUMO-1 Conjugation to Human DNA Topoisomerase II Isozymes
Mao, Y., Desai, S. D., & Liu, L. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001831200 · Cited by 144
Taylor, C. T., Furuta, G. T., Synnestvedt, K., & Colgan, S. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220211797 · Cited by 131
Self-citationSUMO conjugation and deconjugation
Schwienhorst, I., Johnson, E. S., & Dohmen, R. J. (2000) · Molecular and General Genetics MGG · doi:10.1007/s004380000254 · Cited by 128
Endter, C., Kzhyshkowska, J. G., Stauber, R. H., & Dobner, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191361798 · Cited by 115
Chakrabarti, S. R., Sood, R., Nandi, S., & Nucifora, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240315897 · Cited by 115
Nishida, T., Kaneko, F., Kitagawa, M., & Yasuda, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103955200 · Cited by 103
Control of NF–κB transcriptional activation by signal induced proteolysis of IκBα
Hay, R. T., Vuillard, L., Desterro, J. M. P., & Rodriguez, M. S. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0504 · Cited by 89
Taylor, C. T., Fueki, N., Agah, A., Hershberg, R. M., & Colgan, S. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19447 · Cited by 88
Self-citationModification of Daxx by small ubiquitin-related modifier-1
Jang, M.-S., Ryu, S., & Kim, E. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00699-x · Cited by 87
Stimulation of Glucose Transport by Hypoxia: Signals and Mechanisms
Behrooz, A., & Ismail-Beigi, F. (1999) · Physiology · doi:10.1152/physiologyonline.1999.14.3.105 · Cited by 85
SUMO-1 Modification of Bovine Papillomavirus E1 Protein Is Required for Intranuclear Accumulation
Rangasamy, D., Woytek, K., Khan, S. A., & Wilson, V. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007777200 · Cited by 84
Rui, H.-L., Fan, E., Zhou, H.-M., Xu, Z., Zhang, Y., & Lin, S.-C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208099200 · Cited by 83
Association of Activating Transcription Factor 2 (ATF2) with the Ubiquitin-conjugating Enzyme hUBC9
Firestein, R., & Feuerstein, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5892 · Cited by 63
Therapeutic Targets for Hypoxia-Elicited Pathways
Taylor, C. T., & Colgan, S. P. (1999) · Pharmaceutical Research · doi:10.1023/a:1011936016833 · Cited by 49
Self-citationBlagosklonny, M. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204055 · Cited by 32
Rogan, S., & Heaphy, S. (2000) · Virus Genes · doi:10.1023/a:1008139514123 · Cited by 20
Cornelis, G. R., & Denecker, G. (2001) · Nature Medicine · doi:10.1038/83298 · Cited by 15
Research works printed but not linked: 1
- A Behrooz, F Ismail-Beigi News Physiol Sci 14, 105–110 (1999).
Cited by
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
“Intriguingly, SUMO1 is itself hypoxia inducible, suggesting that sumoylation of HIFa, and other targets, modifies the response to hypoxia (Comerford et al., 2003; Lee et al., 2007).”
BackgroundJohnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,675
Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602235103 · Cited by 788
Self-citationSUMO and ubiquitin in the nucleus: different functions, similar mechanisms?
Gill, G. (2004) · Genes & Development · doi:10.1101/gad.1214604 · Cited by 756
“Under conditions of prolonged hypoxia, SUMO modification of the transcription factor CREB was increased, correlating with an increase in SUMO-1 mRNA expression under these conditions (Comerford et al. 2003).”
BackgroundJohannessen, M., Delghandi, M. P., & Moens, U. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.05.001 · Cited by 590
Metadata
- Authors
- Comerford, K. M., Leonard, M. O., Karhausen, J., Carey, R., Colgan, S. P., & Taylor, C. T.
- Affiliations
- University College Dublin (IE)
- The Conway Institute for Biomolecular and Biomedical Research, University College, Dublin, D4 Ireland; and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
- Corresponding author
- Taylor, Cormac T.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-01-27
- Volume
- 100
- Issue
- 3
- Pages
- 986-991
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC298713
- OpenAlex
- W2119653500
- Cited by
- 185
- References
- 56
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 6 · 2019: 7 · 2018: 4 · 2017: 7 · 2016: 5 · 2015: 11 · 2014: 8 · 2013: 13 · 2012: 5
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Health Research Board (DK50189, HL60569)
- Crohn's and Colitis Foundation
- National Institutes of Health (5k08dk002564-04, 1k01dk002682-01, DE13499, DK-50189)
- National Heart, Lung, and Blood Institute (R01HL060569, HL-60569)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK02564, R01DK050189, DK02682, R37DK050189, R29DK050189, DK-50189)
- National Institute of Dental and Craniofacial Research (DE13499, P01DE013499)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- SUMO1, CREB, hypoxia, TNF-α, protein stabilization, post-translational modification, nuclear localization, inflammation resolution, T84 cells
- MeSH terms
- Animals, Hypoxia, Cattle, Cell Line, Enzyme-Linked Immunosorbent Assay, HeLa Cells, Humans, Microscopy, Fluorescence, Models, Biological, Mutation, Peptides, Precipitin Tests, RNA, Messenger, Time Factors, Transcription, Genetic, Transfection, Tumor Necrosis Factor-alpha, Blotting, Northern, Blotting, Western, Gene Products, tat, Mutagenesis, Site-Directed, Cyclic AMP Response Element-Binding Protein, Biotinylation, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Amino Acid Motifs, SUMO-1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.